Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis

Kidney International Reports(2024)10.1016/j.ekir.2024.02.006Source: DataRank Database

Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis is a research paper published in Kidney International Reports (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.48)OA: goldTopics (26)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Randy L. Luciano ORCID,Ashwani Kumar ORCID,Kristin Meliambro,Vijayakumar R. Kakade ORCID,Joji Tokita

Live enrichment

PubMed:38707807 OpenAlex:https://openalex.org/W4391788517

USAMRAA

Grant: HT94252310454

National Institutes of Health

Grant: 1R21AI178705-01

Modelling mechanisms of progressive chronic kidney disease in APOL1 high-risk live-donors using BAC-Transgenic mice

National Institutes of Health

Grant: 5R01DK128087-04

Biomarkers for acute interstitial nephritis in humans

National Institutes of Health

Grant: 5R01DK132274-02

Role of AMP-kinase pathway in the regulation of Minimal change disease-to-FSGS transition

National Institutes of Health

Grant: 1K23DK117065-01A1

Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis

National Institutes of Health

Grant: 1R01DK122164-01

Dichotomous roles of Shroom3 in Tubular cells and Podocytes in native and allograft kidneys

FWCI

0.48

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by-nc-nd

journalhttp://www.kireports.org/article/S2468024924000950/pdf

publisherhttp://www.kireports.org/article/S2468024924000950/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2468024924000950?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468024924000950?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ekir.2024.02.006

Fields of Study

Metabolism, Diabetes, and CancerRenal Diseases and GlomerulopathiesDiabetes Treatment and Management0303 health sciences03 medical and health sciences

Keywords

MedicineMetforminPodocyteFocal segmental glomerulosclerosisInternal medicinePlaceboPharmacologyDiabetes mellitusProteinuriaUrologyOncologyEndocrinologyPathologyKidneyAMP-activated protein kinaseadjunctive therapyphase 2Clinical Researchrandomized trialRC870-923Diseases of the genitourinary system. Urology

Sustainable Development Goals

SDG 0: No poverty